MERRIMACK PHARMACEUTICALS INC (16) | Purchase Agreements (4)

Recent Contracts

Asset Purchase Agreement, dated as of March 27, 2020, between Merrimack Pharmaceuticals, Inc. and Celator Pharmaceuticals, Inc (Filed With SEC on March 30, 2020)
Amendment No. 2 to Asset Purchase Agreement, dated as of June 28, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on July 1, 2019)
Amendment No 1. to Asset Purchase Agreement, dated as of June 24, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on June 24, 2019)
Asset Purchase Agreement, dated as of May 28, 2019, by and between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on May 30, 2019)